Valuation: NEW RAYNPV

Market Cap 41.93M 5.35M 4.58M 4.27M 3.92M 7.36M 512M 7.51M 50.67M 19.75M 256M 20.07M 19.64M 849M P/E 2024
-2.43x
P/E 2025 -2.3x
Enterprise Value 6.97M 889K 761K 710K 652K 1.22M 85.07M 1.25M 8.43M 3.28M 42.63M 3.34M 3.27M 141M EV / Sales 2024
0.15x
EV / Sales 2025 0.16x
Free-Float
64.72%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 48 2020-07-30
Corporate Secretary - 2023-07-10
Director TitleAgeSince
Director/Board Member 76 2013-09-25
Director/Board Member 50 2017-06-19
Chairman 48 2021-05-14
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.38% - - 5.6M
-2.21%-3.74%-40.24%-7.56% 15.82B
+0.15%-1.66%-38.95%-25.06% 6.71B
-0.64%+1.05%-19.08%-13.76% 6.26B
+0.67%+0.42%-0.58%-23.80% 4.32B
+0.65%-1.99%-17.97%-39.46% 3.22B
+1.56%+1.39%+5.88%-35.72% 3.03B
-1.76%-4.50%-45.66%-24.67% 3.03B
-1.28%-1.81%-13.29%-5.45% 2.63B
-1.29%-2.55%+43.88% - 2.41B
Average -0.42%-1.17%-14.00%-21.94% 5.27B
Weighted average by Cap. -0.85%-0.75%-23.78%-17.79%

Financials

2024 2025
Net sales 93.94M 11.98M 10.26M 9.57M 8.78M 16.5M 1.15B 16.82M 114M 44.25M 574M 44.98M 44M 1.9B 130M 16.62M 14.23M 13.28M 12.19M 22.9M 1.59B 23.35M 158M 61.41M 797M 62.42M 61.06M 2.64B
Net income -31.01M -3.95M -3.39M -3.16M -2.9M -5.45M -378M -5.55M -37.47M -14.61M -190M -14.85M -14.52M -628M -20.07M -2.56M -2.19M -2.04M -1.88M -3.52M -245M -3.59M -24.25M -9.45M -123M -9.61M -9.4M -406M
Net Debt -60.71M -7.74M -6.63M -6.18M -5.67M -10.66M -741M -10.87M -73.35M -28.6M -371M -29.06M -28.43M -1.23B -34.96M -4.46M -3.82M -3.56M -3.27M -6.14M -426M -6.26M -42.24M -16.47M -214M -16.74M -16.37M -708M
Logo NEW RAYNPV
New Ray Medicine International Holding Ltd is an investment holding company principally engaged in the distribution and trading of pharmaceutical and the provision of marketing and promotion services. The Company operates its businesses through two segments. The Distribution and Trading of Pharmaceutical and Related Products segment is mainly engaged in the distribution and trading of drugs and chemical reagents for pharmaceutical. The Provision of Marketing and Promotion Services segment is mainly engaged in the provision of marketing and promotion services of drugs and chemical reagents for pharmaceutical. The Company mainly operates its businesses in the domestic market.
Employees
-